ARCHIVES

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

This article is from The Cancer Letter archive.

Vol. 01 No. 49 | December 5, 1975

Download PDF Visit The Full Archive

Related Articles

NCI Program: Hughes Institute Official To Head Cancer Biology

July 23, 1999

DCCP Board Approves Concepts Of $2.6 Million In New Competing Projects, $1.2 Million In Recompetitions

September 25, 1981

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

March 25, 2011

NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain

March 5, 1993

ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs

February 24, 1984

Basic Biology Progress, Improved Survival Since 1971 Described By DeVita At Senate Hearing

February 27, 1981